Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins

Open Biology - Tập 5 Số 3 - Trang 140156 - 2015
Didier Colin1, Karolina Hain1, Lindsey Allan1, Paul R. Clarke1
1Division of Cancer Research, Medical Research Institute, University of Dundee, Jacqui Wood Cancer Centre, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.

Tóm tắt

Anti-cancer drugs that disrupt mitosis inhibit cell proliferation and induce apoptosis, although the mechanisms of these responses are poorly understood. Here, we characterize a mitotic stress response that determines cell fate in response to microtubule poisons. We show that mitotic arrest induced by these drugs produces a temporally controlled DNA damage response (DDR) characterized by the caspase-dependent formation of γH2AX foci in non-apoptotic cells. Following exit from a delayed mitosis, this initial response results in activation of DDR protein kinases, phosphorylation of the tumour suppressor p53 and a delay in subsequent cell cycle progression. We show that this response is controlled by Mcl-1, a regulator of caspase activation that becomes degraded during mitotic arrest. Chemical inhibition of Mcl-1 and the related proteins Bcl-2 and Bcl-x L by a BH3 mimetic enhances the mitotic DDR, promotes p53 activation and inhibits subsequent cell cycle progression. We also show that inhibitors of DDR protein kinases as well as BH3 mimetics promote apoptosis synergistically with taxol (paclitaxel) in a variety of cancer cell lines. Our work demonstrates the role of mitotic DNA damage responses in determining cell fate in response to microtubule poisons and BH3 mimetics, providing a rationale for anti-cancer combination chemotherapies.

Từ khóa


Tài liệu tham khảo

10.1038/nrm3494

10.1016/j.molcel.2007.03.019

10.1158/1535-7163.MCT-08-1084

10.1016/j.ccr.2009.08.020

10.1016/j.cub.2006.04.043

10.1016/j.ccr.2008.07.002

10.1016/j.devcel.2004.09.002

10.1158/0008-5472.CAN-07-6699

10.1016/j.ccr.2010.10.028

10.1016/j.tcb.2008.12.003

10.1038/emboj.2010.112

10.1038/nature09779

10.1128/MCB.00882-09

10.1016/j.cub.2010.08.018

10.1038/nsmb.2245

10.1242/jcs.081612

10.1091/mbc.e11-09-0781

10.1038/sj.cdd.4402108

10.1101/gad.1447006

10.1158/0008-5472.CAN-09-1947

10.1038/nature08467

10.1083/jcb.200906064

10.1073/pnas.0709443104

10.1158/0008-5472.CAN-04-2727

10.1038/bjc.2011.243

10.1016/j.bmcl.2004.09.060

10.1158/0008-5472.CAN-05-4275

10.1038/nsmb.2076

Jackson JR, 2000, An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage, Cancer Res., 60, 566

10.1158/0008-5472.CAN-07-5836

10.1158/0008-5472.CAN-10-4336

10.1038/emboj.2009.253

10.1016/j.devcel.2010.03.014

10.1038/34112

10.1126/science.1248024

10.1083/jcb.200911156

10.1126/science.1210214

10.1038/nature10802

10.1016/j.cell.2013.06.007

10.1093/nar/gku501

10.1038/ncb1738

10.1016/S0165-4608(01)00575-1

Thông tin
Thông tin xuất bản

Open Biology

Tập 5 Số 3

140156

Thông tin tác giả